View all cases
- Case details
- Status—ActionCounterclaim for revocationCategoryCounterclaim for revocation
- Parties
- Claimants
- Accord Healthcare S.L.U.Operating co.
- Accord Healthcare GmbHOperating co.
- Accord Healthcare B.V.Operating co.
- Accord Healthcare Italia SrlOperating co.
- Accord Healthcare ABOperating co.
- STADAPHARM GmbHOperating co.
- STADA Arzneimittel AGOperating co.
- STADA Nordic ApSOperating co.
- Reddy Pharma SASOperating co.
- betapharm Arzneimittel GmbHOperating co.
- Dr Reddy's SrlOperating co.
- Zentiva FranceOperating co.
- Zentiva Pharma GmbHOperating co.
- Zentiva, k.s.Operating co.
Representatives- Jules Fabre-Pinsent Masons
- Daniel Hoppe-Bonabry
- Christian Meyer-Maiwald
- Anja Lunze-Taylor Wessing
- Arjan Reijns-Pinsent Masons
- Louise Millot-Pinsent Masons
- Andreas Ledl-Maiwald
- Elisabeth Greiner-df-mp
Respondents- Sanofi SAOperating co.
- Sanofi Winthrop IndustrieOperating co.
- Sanofi-Aventis GmbHOperating co.
- Sanofi BelgiumOperating co.
- Sanofi-Aventis Deutschland GmbHOperating co.
- Sanofi S.r.l.Operating co.
- Sanofi B.V.Operating co.
- Sanofi - Produtos Farmaceuticos LdaOperating co.
- Sanofi ABOperating co.
- Sanofi A/SOperating co.
Representatives- Frédéric Chevallier-Herbert Smith Freehills Kramer LLP
- Division
- Munich LD
- Judges
- —
- Technology
- ChemistryPharmaceuticals
- Language
- —
- First decided
- Jan 24, 2025
- EPO Opposition
- Glenmark Pharmaceuticals Europe Ltd2021-03-10
- Accord Healthcare LtdAdmissible2021-03-10
- Teva Pharmaceutical Industries Ltd.Admissible2021-03-10
- EVER Valinject GmbHWithdrawn2021-03-12
- Zentiva k.s.Admissible2021-03-12
- medac Gesellschaft für klinische Spezialpräparate mbHWithdrawn2021-03-22
- Fresenius Kabi Deutschland GmbHAdmissible2021-03-23
- Dr. Reddy's Laboratories Ltd.Admissible2021-03-31
- Betapharm Arzneimittel GmbHAdmissible2021-03-31
- Generics (U.K.) LimitedAdmissible2021-06-08
- Vossius & Partner Patentanwälte Rechtsanwälte mbBAdmissible2021-12-03
- STADA Arzneimittel AGAdmissible2021-12-09
- Maiwald GmbHAdmissible2021-12-10
- Accord Healthcare S.L.U.2024-08-30
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
| Patent revoked | Median days to first decision | |
|---|---|---|
| All UPC | 37% (34/91) | 124 |
| Munich LD | Locked | Locked |
At the UPC: Accord Group (8 cases)·Sanofi Group (33 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 18 other proceedings
UPC CoA 22/2026·UPC CoA 23/2026·UPC CoA 24/2026·UPC CoA 25/2026·UPC CFI 106/2026 and 13 more
5 other defendants litigating the same or a related patent
UPC CoA 26/2026·UPC CoA 27/2026·UPC CFI 503/2024·UPC CFI 463/2024·UPC CFI 374/2024
Decisions
- 2025-01-24Counterclaim for revocationPublic
Summary: The Munich Local Division issued a procedural order in the infringement actions by Sanofi (and successor entities) against multiple generic pharmaceutical companies (Accord, STADA, Dr Reddy's, Zentiva) concerning EP 2 493 466 (UPC_CFI_145/2024 and related cases). The order concerns case management — identifying parties and representatives across the eight consolidated cases relating to counterclaims for revocation.
Show the legal issues (2)
- Procedural case management across consolidated actions
- Counterclaim for revocation in pharmaceutical patent infringement
Documents
- E0978D775DB2B7D9B841677C65040675_en.pdf2025-01-24EN